LCM
MRNA icon

Legato Capital Management’s Moderna MRNA Stock Holding History

Legato Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,385
Closed -$828K – 601
2024
Q3 		$828K Hold
12,385
– – 0.1% 350
2024
Q2 		$1.47M Sell
12,385
-6,500
-34% -$823K 0.2% 180
2024
Q1 		$2.01M Buy
18,885
+8,000
+73% +$806K 0.24% 127
2023
Q4 		$1.08M Hold
10,885
– – 0.14% 241
2023
Q3 		$1.12M Buy
10,885
+4,500
+70% +$502K 0.16% 211
2023
Q2 		$776K Hold
6,385
– – 0.1% 311
2023
Q1 		$981K Hold
6,385
– – 0.18% 198
2022
Q4 		$1.15M Buy
+6,385
New +$1.04M 0.22% 151

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Legato Capital Management's MRNA Position: Q4 2024 in Review

Legato Capital Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 12,385 shares — an estimated $828K sold.

Legato Capital Management first reported a position in MRNA in Q4 2022 and held it in 8 quarters. The position peaked at $2.01M in Q1 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Legato Capital Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Legato Capital Management sold 12,385 Moderna shares in Q4 2024, an estimated $828K.
  • Legato Capital Management first reported a position in Moderna in Q4 2022 and held it in 8 quarters.
  • Legato Capital Management's Moderna position peaked at $2.01M in Q1 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Legato Capital Management's 13F filing for Q4 2024, filed 29 Jan 2025.